Tianhong Shengjie Raises Tens of Millions RMB in Equity Round for Peripheral Vascular Devices

Suzhou Tianhong Shengjie Medical Devices raised a tens-of-millions-of-RMB equity round led solely by Chuangjing Capital.

Win-Cross Capital served as advisor on the deal.

The company will use the funds to accelerate R&D and commercialization of its peripheral vascular product pipelines.

The financing backs a Chinese medtech player with a first-approved iliac vein stent in a fast-growing market with strong unmet need.